Country specific reports on the topic are available for purchase. Please contact us.
GlobalData, the industry analysis specialist, has released its new report, "Healthcare, Regulatory and Reimbursement Landscape - India". The report is an essential source of information and analysis on India's healthcare, regulatory and reimbursement landscape. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory and reimbursement landscape and healthcare infrastructure. Most importantly, it provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. The report is built using data and information sourced from proprietary databases, secondary research and in-house analysis by GlobalData's team of industry experts.
India is the second most populated country in the world with a population of approximately 1.21 billion in 2011, although the growth rate of the population is declining due to a decrease in the birth rate and an increase in net emigration. Unlike China and Japan, the working-age population accounts for the majority of the overall population. In order to derive maximum benefit, the government is currently working to develop human capital by increasing its spending on health and education. The country's pharmaceutical market was valued at $12.9 billion in 2010 and is expected to reach approximately $54 billion by 2020 at a Compound Annual Growth Rate (CAGR) of 15.4%, primarily attributed to -
The report provides information on India's healthcare, regulatory and reimbursement landscape, and includes -
This report will enhance your decision-making capability by allowing you to -
Browse more Drug Regulation Market Research Reports